CEO Executive AssistantHospice care occupies a uniquely sensitive position in healthcare leadership. The clinical, regulatory, and community dimensions of hospice program management demand consistent strategic attention from the CEO, while the operational complexity of managing a distributed clinical workforce, navigating CMS reimbursement and quality frameworks, and expanding referral partnerships across healthcare systems creates a demanding coordination challenge. For the healthcare CEO overseeing hospice program coordination, an executive assistant who understands the regulatory calendar, clinical quality reporting cycles, and stakeholder relationship demands of the hospice sector is a meaningful operational asset.
This article covers the five core areas where skilled EA support has the most impact for healthcare CEOs managing hospice programs.
Scheduling Hospice Medical Director Leadership Reviews
The hospice medical director plays a central clinical governance role: certifying patient eligibility for the hospice benefit, overseeing physician services, ensuring clinical practice aligns with comfort-focused care standards, and leading the interdisciplinary team’s clinical decision-making. For a CEO managing a multi-site hospice program, regular structured engagement with hospice medical directors is an operational and quality governance requirement, not just a courtesy.
Medical director leadership reviews should occur at a defined cadence, typically monthly at the program level and quarterly at the enterprise level for organizations with multiple hospice locations. The EA establishes these recurring sessions, coordinates attendance from the CEO, the chief medical officer, and the regional medical directors as appropriate, and ensures that preparation materials arrive in advance to support a focused and productive review.
Structuring Medical Director Review Preparation
Preparation materials for a hospice medical director leadership review should cover clinical quality metrics (pain and symptom management rates, live discharge rates, emergency department utilization), patient eligibility and recertification metrics, any significant clinical incidents or quality concerns that have arisen in the review period, and any regulatory developments affecting medical director clinical responsibilities.
The EA coordinates the assembly of this package from the clinical operations team and the quality team, sets internal submission deadlines, and ensures the CEO has review time scheduled before the session begins. When a medical director review surfaces a clinical quality concern requiring CEO-level attention, the EA ensures a follow-up briefing is scheduled with the appropriate clinical and quality leadership to brief the CEO on the corrective action plan and timeline.
For related coordination frameworks on managing clinical quality and compliance cycles, see credentialing and privileging coordination support, where similar rhythms of structured review, documentation management, and follow-up tracking apply to physician and clinical staff credentialing.
Coordinating CMS Hospice Quality Reporting Briefings
The Centers for Medicare and Medicaid Services (CMS) governs hospice reimbursement and quality reporting through the Hospice Quality Reporting Program (HQRP). The HQRP requires hospice providers to submit quality measure data, participate in the CAHPS Hospice Survey, and comply with ongoing Conditions of Participation. Failure to meet HQRP reporting requirements results in a reimbursement payment reduction, and patterns of quality concern can trigger enhanced CMS oversight or survey activity.
The CEO needs regular briefings on the organization’s CMS compliance status, quality reporting performance, and any regulatory developments that may affect the hospice program’s regulatory standing. The EA maintains the CMS quality reporting calendar, which includes data submission deadlines, public reporting release dates when Quality Care Finder scores are updated, and any active CMS correspondence or survey activity requiring a response.
Managing CMS Compliance Briefing Timing
CMS quality reporting briefings for a hospice CEO should be scheduled at defined points in the regulatory calendar: before each data submission deadline to ensure the CEO is aware of the submission and its contents; after each public reporting update to brief the CEO on the organization’s published quality scores relative to national benchmarks; and immediately when any CMS survey activity, deficiency citation, or correspondence requires a CEO-level decision or response.
The compliance team and quality team are the primary sources for CMS briefing preparation. The EA coordinates the briefing request, establishes a preparation deadline, confirms that the briefing document includes a clear summary of the organization’s current compliance status and any actions required, and schedules the CEO review at the appropriate point in the calendar. When a CMS finding requires a formal Plan of Correction, the CEO needs to review and approve the plan before submission. The EA manages the timeline to ensure that review happens with adequate preparation time before the submission deadline.
Tracking CAHPS Hospice Survey Reporting Cycles
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) Hospice Survey measures the experience of caregivers and families who cared for a recently deceased patient who received hospice services. CAHPS Hospice scores are publicly reported on the CMS Care Compare website and are a key component of hospice quality transparency for referral partners, families, and payers. For a hospice CEO, CAHPS performance is both a quality indicator and a competitive differentiator.
CAHPS Hospice surveys are administered on an ongoing basis by a CMS-approved survey vendor, with results compiled and publicly reported on a defined schedule. The EA maintains the CAHPS reporting calendar, coordinates the delivery of interim survey data from the survey vendor to the CEO and quality leadership on a regular schedule, and ensures that the CEO receives a briefing before each public reporting update that covers the organization’s expected scores and how they compare to prior reporting periods and national benchmarks.
Connecting CAHPS Data to Operational Improvement
CAHPS scores are most useful when they are connected to operational actions. A declining score on “communication about medicines” or “getting timely care” tells the CEO something specific about where the clinical experience is falling short. The EA coordinates the scheduling of CAHPS data review sessions that bring together the clinical quality team, the clinical education team, and the CEO to review score trends and agree on operational improvement priorities.
These CAHPS improvement sessions should be distinct from the broader medical director leadership review cycle; the CAHPS data deserves dedicated attention because it reflects the family and caregiver experience, which is the most visible quality signal to referral partners and to the families the organization serves. The EA maintains the action item log from CAHPS review sessions and tracks improvement initiative progress against the timeline the team has committed to.
Managing Community Referral Partnership Meetings
Hospice programs grow through referral relationships with hospitals, health systems, physicians, skilled nursing facilities, and home health agencies. The CEO’s direct engagement with the leaders of major referral partners is one of the most important business development activities in hospice, and it requires consistent, well-prepared relationship management.
Referral partnership meetings at the CEO level are typically relationship maintenance and strategic alignment conversations rather than transactional sales calls. The CEO is engaging with a hospital CEO, a health system CMO, or a skilled nursing facility administrator to reinforce the partnership, address any service concerns, and explore opportunities to deepen or expand the relationship. This requires preparation that combines operational data (referral volume, hospice election rates, length of service for referred patients, any service quality issues) with relationship context (history of the partnership, prior commitments, any competitive dynamics).
Coordinating the Referral Partner Briefing Process
The EA coordinates referral partner briefing preparation with the business development team and the clinical operations team, establishing a preparation deadline two to three days before each CEO-level referral partner meeting. The briefing document should cover: the partner’s referral volume and trend, hospice election rates for referred patients, any service quality feedback received from the partner in the recent period, the history of the CEO-level relationship, and talking points for the specific agenda of this meeting.
When a referral partner meeting surfaces a service concern that requires follow-up, the EA captures the commitment and coordinates with the clinical operations team to ensure the response reaches the referral partner promptly. In hospice, where referral partners are making decisions about where to send their most vulnerable patients, responsiveness to service concerns is a direct influence on referral volume.
For related community and partnership relationship frameworks, see home health coordination support, where parallel approaches to referral partnership management and community relationship maintenance apply to a closely related post-acute care setting.
Preparing Board Presentations on Hospice Program Strategy
The board of directors for a healthcare organization with hospice operations expects regular reporting on the hospice program’s performance, quality, and strategic direction. Quarterly board presentations on hospice program strategy should cover census trends, clinical quality metrics, CAHPS performance, CMS compliance status, financial performance, and the strategic roadmap for geographic service area expansion or program investment.
Board presentation preparation for hospice typically runs on a three-to-four week cycle before each board meeting, with defined milestones for first draft, executive review, and final formatting. The EA coordinates content collection from the finance team, the clinical quality team, the compliance team, and the business development team; manages the master presentation file with version control; and schedules the CEO’s review sessions at the right points in the preparation cycle.
Structuring the Hospice Board Narrative
The board narrative for hospice program strategy needs to address several dimensions. Census performance is the primary volume metric: average daily census, admissions trends, average length of service, and live discharge rates. The board needs to understand not just whether census is growing but whether the patient population being served reflects appropriate hospice utilization (adequate length of service, appropriate diagnoses) rather than patterns that could attract CMS scrutiny.
Clinical quality metrics should be presented in the context of national benchmarks. CMS makes benchmark data publicly available through the HQRP, and the board expects to see how the organization compares to state and national averages on key quality measures. CAHPS scores belong in this section as well, with trend data that shows whether the patient and family experience is improving over time.
Geographic service area expansion is a recurring strategic topic for hospice boards. Certificate of Need requirements vary by state, and market entry in a new county or region requires analysis of referral partner relationships, competitive landscape, physician coverage, and operational infrastructure. McKinsey’s research on healthcare service line strategy underscores the importance of disciplined market selection and service differentiation in post-acute care expansion. The CEO’s board presentation on hospice expansion strategy should reflect this rigor: a clear analysis of the opportunity, a realistic assessment of the investment required, and a defined set of metrics that will be used to evaluate whether the expansion is succeeding.
The EA ensures that the expansion strategy narrative is integrated coherently with the operational and quality reporting sections, so the board sees a complete picture of how the current program is performing and where the strategic investment priorities will take it.
Why Hospice Program Coordination Requires a Specialized Support Framework
Hospice program management is operationally intensive and emotionally consequential in a way that distinguishes it from many other healthcare service lines. The regulatory compliance demands are significant and ongoing. The clinical quality signals are meaningful indicators of whether the organization is fulfilling its core mission. The referral relationships are personal and trust-based. And the board and investor expectations for quality and growth are high.
For the healthcare CEO navigating all of this, an executive assistant who understands the hospice regulatory calendar, the CMS reporting cycle, the CAHPS survey program, and the referral partnership dynamics of the post-acute care market provides materially better support than one who is learning the sector from scratch. The combination of medical director review management, CMS compliance briefing coordination, CAHPS tracking, referral partnership meeting support, and board presentation preparation represents a complete hospice program coordination framework that enables the CEO to lead with confidence, consistency, and strategic clarity.